A detailed history of Wedbush Securities Inc transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Wedbush Securities Inc holds 15,412 shares of HQL stock, worth $205,287. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,412
Previous 20,112 23.37%
Holding current value
$205,287
Previous $271,000 22.51%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$13.38 - $14.33 $62,886 - $67,351
-4,700 Reduced 23.37%
15,412 $210,000
Q4 2023

Feb 12, 2024

SELL
$11.35 - $13.6 $29,782 - $35,686
-2,624 Reduced 11.54%
20,112 $271,000
Q3 2023

Nov 14, 2023

BUY
$12.38 - $13.69 $37,140 - $41,070
3,000 Added 15.2%
22,736 $284,000
Q2 2023

Aug 14, 2023

BUY
$13.13 - $14.17 $22,636 - $24,429
1,724 Added 9.57%
19,736 $267,000
Q1 2023

May 09, 2023

BUY
$13.37 - $14.94 $16,712 - $18,675
1,250 Added 7.46%
18,012 $251,000
Q4 2022

Jan 31, 2023

BUY
$13.55 - $15.23 $33,197 - $37,313
2,450 Added 17.12%
16,762 $238,000
Q3 2022

Oct 18, 2022

BUY
$13.39 - $16.31 $4,258 - $5,186
318 Added 2.27%
14,312 $195,000
Q2 2022

Jul 21, 2022

BUY
$13.11 - $17.02 $10,802 - $14,024
824 Added 6.26%
13,994 $199,000
Q1 2022

Apr 19, 2022

BUY
$15.35 - $19.29 $45,666 - $57,387
2,975 Added 29.18%
13,170 $217,000
Q4 2021

Jan 13, 2022

BUY
$18.5 - $21.59 $2,016 - $2,353
109 Added 1.08%
10,195 $196,000
Q3 2021

Oct 08, 2021

SELL
$20.27 - $22.67 $344 - $385
-17 Reduced 0.17%
10,086 $209,000
Q2 2021

Jul 27, 2021

BUY
$19.14 - $21.44 $193,371 - $216,608
10,103 New
10,103 $216,000
Q2 2019

Aug 01, 2019

SELL
$15.54 - $17.47 $169,588 - $190,650
-10,913 Closed
0 $0
Q1 2019

Apr 17, 2019

BUY
$15.5 - $17.9 $169,151 - $195,342
10,913 New
10,913 $187,000
Q4 2018

Jan 31, 2019

SELL
$13.99 - $20.35 $163,780 - $238,237
-11,707 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$18.89 - $20.49 $221,145 - $239,876
11,707 New
11,707 $239,000

Others Institutions Holding HQL

About TEKLA LIFE SCIENCES INVESTORS


  • Ticker HQL
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...
More about HQL
Track This Portfolio

Track Wedbush Securities Inc Portfolio

Follow Wedbush Securities Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.